Next Article in Journal
89Zr-girentuximab PET/CT Enables Noninvasive Assessment of Indeterminate Renal Masses and Metastatic Clear-Cell Renal Cell Carcinoma
Previous Article in Journal
Nucleic-Acid-Based Strategies and Nanotechnology Applications for Targeted Therapy
Previous Article in Special Issue
Ambivalent Copper: Mechanistically Distinct Immune Effects Driving Innovation in Cancer Nanomedicine
 
 
Article

Article Versions Notes

Pharmaceutics 2026, 18(2), 257; https://doi.org/10.3390/pharmaceutics18020257
Action Date Notes Link
article html file updated 26 February 2026 03:32 CET Update https://www.mdpi.com/1999-4923/18/2/257/html
article pdf uploaded. 26 February 2026 03:29 CET Updated version of record https://www.mdpi.com/1999-4923/18/2/257/pdf
article xml uploaded. 26 February 2026 03:29 CET Update https://www.mdpi.com/1999-4923/18/2/257/xml
article xml file uploaded 26 February 2026 03:29 CET Update -
article html file updated 26 February 2026 02:26 CET Original file -
article pdf uploaded. 26 February 2026 02:22 CET Updated version of record https://www.mdpi.com/1999-4923/18/2/257/pdf-vor
article xml uploaded. 26 February 2026 02:22 CET Update -
article xml file uploaded 26 February 2026 02:22 CET Original file -
article pdf uploaded. 19 February 2026 09:23 CET Updated version of record https://www.mdpi.com/1999-4923/18/2/257/pdf-vor
article supplementary file uploaded. 19 February 2026 09:04 CET - https://www.mdpi.com/1999-4923/18/2/257#supplementary
article pdf uploaded. 19 February 2026 09:04 CET Version of Record https://www.mdpi.com/1999-4923/18/2/257/pdf-vor
Back to TopTop